Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor
The article investigates the value of canagliflozin in the management of type 2 diabetes mellitus from the perspective of a clinically-based patient-centred approach. It focusses on the outcomes of a 52-week double-blind, active-controlled study. The results of this clinical trial demonstrate that c...
Saved in:
| Main Authors: | Nina A. Petunina, Anna L. Terekhova, Ekaterina V. Goncharova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2016-12-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/7949 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of measurement properties of the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument among Chinese overweight and obese populations
by: Xinran Liu, et al.
Published: (2024-11-01) -
Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus
by: A. V. Simanenkova, et al.
Published: (2021-07-01) -
Accuracy of volume measurements by a clinical spirometer in multiple veterinary hospitals
by: Mathieu Raillard, et al.
Published: (2024-12-01) -
Measuring quality of life in clinical research – Part 1
by: Priya Ranganathan, et al.
Published: (2025-07-01) -
Canagliflozin‐induced renal glutathione distribution mapping in non‐diabetic male rat kidneys
by: Guy Watanabe, et al.
Published: (2025-04-01)